Compare watchful waiting vs endoscopy treatment for Barrett’s with low-grade dysplasia
Part of Cancer, Digestive system clinical trials.
This trial compares two approaches for people with Barrett’s esophagus and low-grade dysplasia: regular monitoring versus treatment done through an endoscopy. It aims to see which approach is safer and better at preventing progression to more serious changes in the esophagus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and able to sign an informed consent form
- Have confirmed Barrett’s esophagus in the esophagus (not the stomach opening) with low-grade dysplasia on biopsy
- Have had biopsy-proven Barrett’s with low-grade dysplasia within the last 12 months
- Be able to take proton pump inhibitor (PPI) medicine (stomach acid medicine) as directed
- Be able to safely stop blood thinners (antiplatelet and anticoagulant) around the time of endoscopy, if your doctor recommends it
- Not be pregnant, and not have had prior endoscopic eradication therapy for Barrett’s
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether it's safe to stop regular surveillance endoscopies for people with low-risk Barrett's esophagus. If you have a short Barrett's segment without any dysplasia, you may be able to avoid future procedures.
This study compares two endoscopic treatments to remove abnormal cells in Barrett’s esophagus and lower the chance of it worsening. If you qualify, you may be assigned to one of the two procedures and followed to see how well they work and how safe they are.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This trial tests whether a medication called ursodeoxycholic acid (UDCA) can improve the results of endoscopic therapy for Barrett's esophagus, a condition that can lead to esophageal cancer. If you are already taking UDCA and have had or are planning ablation treatment, the study will see if it helps your esophagus heal more completely.
This study compares two ways doctors remove abnormal tissue in the esophagus during endoscopy: EMR versus ESD. It may help improve how safely and completely these lesions are removed, while also comparing outcomes between the two methods.
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
Hear when a new Barretts Esophagus With Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.